
| OPPONENT | AB | R | H | 1B | 2B | 3B | HR | BB | RBI | SO | SAC | SB | AVG | SLG | OB | OPS | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASCO | 2 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | .000 | .000 | .000 | .000 | |
| Novartis #2 | 2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | .000 | .000 | .000 | .000 | |
| Evonik | 2 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 2 | 1 | 0 | 0 | .500 | .500 | .500 | 1.000 | |
| Mondelez | 3 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | .000 | .000 | .000 | .000 | |
| Pinnacle | 2 | 0 | 1 | 1 | 0 | 0 | 0 | 1 | 1 | 1 | 0 | 0 | .500 | .500 | .667 | 1.167 | |
| Celgene #2 | 1 | 2 | 1 | 1 | 0 | 0 | 0 | 3 | 1 | 0 | 0 | 0 | 1.000 | 1.000 | 1.000 | 2.000 | |
| Novartis #1 | 3 | 0 | 3 | 2 | 1 | 0 | 0 | 0 | 3 | 0 | 0 | 0 | 1.000 | 1.333 | 1.000 | 2.333 | |
| TOTAL | 15 | 4 | 6 | 5 | 1 | 0 | 0 | 4 | 7 | 3 | 0 | 0 | .400 | .467 | .526 | .993 |